Immune checkpoint inhibitors–related encephalitis in melanoma and non-melanoma cancer patients: a single center experience

BACKGROUND: Treatment with immune checkpoint inhibitors (ICI) has greatly improved survival for patients with a number of malignant diseases in recent years. Neurological immune-related adverse events (n-irAE) of varying severity have been reported in the literature. We aimed to identify the inciden...

Descripción completa

Detalles Bibliográficos
Autores principales: Taliansky, A., Furman, O., Gadot, M., Urban, D., Bar, J., Shapira-Frumer, R., Kaufman, B., Asher, N., Leibowitz-Amit, R., Itay, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550117/
https://www.ncbi.nlm.nih.gov/pubmed/34120259
http://dx.doi.org/10.1007/s00520-021-06331-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550117/
https://www.ncbi.nlm.nih.gov/pubmed/34120259
http://dx.doi.org/10.1007/s00520-021-06331-5

Ejemplares similares